About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:2686875
Allelic
Composition
Fgf8tm1Mrc/Fgf8tm1Moon
Tfap2atm1(cre)Moon/Tfap2a+
Genetic
Background
involves: 129/Sv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgf8tm1Moon mutation (1 available); any Fgf8 mutation (18 available)
Fgf8tm1Mrc mutation (0 available); any Fgf8 mutation (18 available)
Tfap2atm1(cre)Moon mutation (1 available); any Tfap2a mutation (39 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• those that survive to birth die postnatally due to lethal vascular defects in 30% and severe craniofacial defects in 100% of mutants
• 25% die prior to birth

cardiovascular system
• 30% show lethal vascular defects, however outflow tract development is normal
• 95% have abnormal fourth pharyngeal arch artery formation at E10.5
• migration and early differentiation of the 4th pharyngeal arch artery endothelial cells occurs normally but subsequent vascular organization fails such that at the 35-37 somite stage, endothelial cells remain disorganized and fail to form primitive vascular tubes, long after this vessel is patent and pericyte recruitment is under way in controls
• 33% display bilateral aplasia of the fourth and sixth pharyngeal arch arteries at E10.5
• 12% show bilateral hypoplasia of the 4th pharyngeal arch arteries
• 33% display bilateral aplasia of the fourth and sixth pharyngeal arch arteries at E10.5
• exhibit an abnormally large third pharyngeal arch artery
• 30% of E18.5 mutants have interrupted aortic arch type B (IAAB)
• 13% exhibit circumflex right aortic arch (RAA) or RAA with right ductus arteriosus
• 46% exhibit coronary artery anomalies, in isolation or associated with other vascular defects
• subclavian artery anomalies
• 80% exhibit retroesophageal right subclavian artery or abnormal subclavian branching associated with other defects

craniofacial
• 100% show severe craniofacial malformations
• 95% have abnormal fourth pharyngeal arch artery formation at E10.5
• migration and early differentiation of the 4th pharyngeal arch artery endothelial cells occurs normally but subsequent vascular organization fails such that at the 35-37 somite stage, endothelial cells remain disorganized and fail to form primitive vascular tubes, long after this vessel is patent and pericyte recruitment is under way in controls
• 33% display bilateral aplasia of the fourth and sixth pharyngeal arch arteries at E10.5
• 12% show bilateral hypoplasia of the 4th pharyngeal arch arteries
• 33% display bilateral aplasia of the fourth and sixth pharyngeal arch arteries at E10.5
• exhibit an abnormally large third pharyngeal arch artery
• exhibit severe pharyngeal arch 1 hypoplasia and hypoplasia and fusion of the more caudal pharyngeal arches as early as E9.5

embryo
• 95% have abnormal fourth pharyngeal arch artery formation at E10.5
• migration and early differentiation of the 4th pharyngeal arch artery endothelial cells occurs normally but subsequent vascular organization fails such that at the 35-37 somite stage, endothelial cells remain disorganized and fail to form primitive vascular tubes, long after this vessel is patent and pericyte recruitment is under way in controls
• 33% display bilateral aplasia of the fourth and sixth pharyngeal arch arteries at E10.5
• 12% show bilateral hypoplasia of the 4th pharyngeal arch arteries
• 33% display bilateral aplasia of the fourth and sixth pharyngeal arch arteries at E10.5
• exhibit an abnormally large third pharyngeal arch artery
• exhibit an increase in apoptosis of neural crest cells migrating from rhombomeres 6-8
• exhibit severe pharyngeal arch 1 hypoplasia and hypoplasia and fusion of the more caudal pharyngeal arches as early as E9.5

cellular
• exhibit an increase in apoptosis of neural crest cells migrating from rhombomeres 6-8


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory